Aphria Controversy Makes This Under-the-Radar Marijuana Stock a Bigger Bargain Motley Fool
A short-seller’s attack on Aphria casts a dark cloud over Liberty Health Sciences, too. But the prospects for Liberty still look sunny.
Your email address will not be published. Required fields are marked *